by The global microneedle drug delivery systems market size is expected to be worth around US$ 12.1 billion by 2030, according to a new report by Vision Research Reports.
The global microneedle drug delivery systems market size was valued at US$ 8.7 billion in 2020 and is anticipated to grow at a CAGR of 6.3% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38803
Table of Contents
Microneedle Drug Delivery Systems Market Growth Factors
The growing demand for safer alternatives to the conventional hypodermic injection and increasing awareness regarding minimally invasive and pain-free administration of drugs are expected to boost the market growth. Furthermore, the increasing cases of diabetes are expected to boost the market growth. For instance, according to the International Diabetes Federation (IDF), the number of diabetics has already reached 463 million and is predicted to rise in the next 10 years.
Drug delivery via microneedles is one of the most efficient procedures compared to traditional hypodermic injections. Microneedles are a self-administering platform for transdermal medication delivery that has a high drug bioavailability.
Microneedle Drug Delivery Systems Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 12.1 Bn by 2030 |
| Growth Rate | CAGR of 6.3% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, material, application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Raphas; Novartis International AG; Becton Dickinson and Company; B. Braun; Nanopass Technologies Limited; Termo; Smiths Medical; Cardinal Health; 3M |
By Type Analysis
The hollow microneedle segment accounted for the largest revenue share of more than 26.0% in 2020. Hollow microneedles are commonly used to deliver vaccines and hormones, which include insulin for diabetic patients.
The dissolving microneedle segment is expected to grow at the fastest rate during the forecast period. As the dissolving microneedle is a less painful method of delivering active ingredients than the syringe, it only requires one step as the microneedle needs not to be removed after insertion.
By Material Analysis
The metal material segment accounted for the largest revenue share of more than 27.0% in 2020. Stainless steel and titanium are the most frequently employed metals. Other metals used are palladium, nickel, and palladium-cobalt alloys.
The silicone material segment is estimated to witness considerable growth from 2021 to 2028. The segment growth can be attributed to its flexibility, which allows it to produce needles of various sizes and shapes. It is a versatile material due to its attractive physical features.
By Application Analysis
The drug delivery segment held the largest revenue share of more than 36.0% in 2020. Insulin is a hormone that is made up of peptides. The drug is recommended for patients with high blood sugar levels.
The vaccine delivery segment is expected to expand at the fastest CAGR of 7.3% from 2021 to 2030. The increased awareness regarding vaccination among the population has led scientists to develop new approaches to vaccine administration.
By Regional Analysis
North America dominated the market and accounted for a revenue share of over 40.0% in 2020. Patient outcomes and safety are of utmost importance in the U.S., and different projects have been formed to improve healthcare quality and reduce costs.
In Asia Pacific, the market is estimated to register the fastest CAGR during the forecast period. The spread of the COVID-19 pandemic across APAC has highlighted shortcomings and faults in the region’s healthcare system and the interconnectedness between health security and economic stability.
Read also @ Diabetes Associated Ophthalmic Treatment Market Share by 2030
Major Key Players Covered in The Microneedle Drug Delivery Systems Market Report include
- Raphas
- Novartis International AG
- Becton Dickinson and Company
- B. Braun
- Nanopass Technologies Limited
- Termo
- Smiths Medical
- Cardinal Health
- 3M
Microneedle Drug Delivery Systems Market Segmentation
- By Type
- Solid
- Hollow
- Dissolving
- Coated
- Others
- By Material
- Silicon
- Metal
- Polymer
- Others
- By Application
- Dermatology
- Drug Delivery
- Pain Management
- Cancer Therapy
- Vaccine Delivery
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Microneedle Drug Delivery Systems Market, By Type
7.1. Microneedle Drug Delivery Systems Market, by Type, 2021-2030
7.1.1. Solid
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Hollow
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Dissolving
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Coated
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Microneedle Drug Delivery Systems Market, By Material
8.1. Microneedle Drug Delivery Systems Market, by Material, 2021-2030
8.1.1. Silicon
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Metal
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Polymer
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Microneedle Drug Delivery Systems Market, By Application
9.1. Microneedle Drug Delivery Systems Market, by Application, 2021-2030
9.1.1. Dermatology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Drug Delivery
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Pain Management
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Cancer Therapy
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Vaccine Delivery
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Microneedle Drug Delivery Systems Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Material (2017-2030)
10.1.3. Market Revenue and Forecast, by Application (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Material (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Material (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Material (2017-2030)
10.2.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Material (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Material (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Material (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Material (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Material (2017-2030)
10.3.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Material (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Material (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Material (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Material (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Material (2017-2030)
10.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Material (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Material (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Material (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Material (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Material (2017-2030)
10.5.3. Market Revenue and Forecast, by Application (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Material (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Application (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Material (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
Chapter 11. Company Profiles
11.1. Raphas
11.1.1. Company Overview
11.1.2. Type Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Novartis International AG
11.2.1. Company Overview
11.2.2. Type Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Becton Dickinson and Company
11.3.1. Company Overview
11.3.2. Type Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. B. Braun
11.4.1. Company Overview
11.4.2. Type Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Nanopass Technologies Limited
11.5.1. Company Overview
11.5.2. Type Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Termo
11.6.1. Company Overview
11.6.2. Type Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Smiths Medical
11.7.1. Company Overview
11.7.2. Type Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cardinal Health
11.8.1. Company Overview
11.8.2. Type Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. 3M
11.9.1. Company Overview
11.9.2. Type Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38803
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
